Curia’s Health, Care, and Life Sciences Research Group has submitted their implementation plan for how a new government can implement their plans for a new Life Sciences Industrial Strategy. Subscribers will receive an exclusive copy of the report.
New subscribers will receive a copy of the report, alternatively a copy can be purchased at www.chamberuk.com/shop.
This article outlines some of the key learnings from the document and a short summary of a case study.
Key Learning: Investment, Jobs, and Growth
The removal of EU State Aid restrictions provides a unique opportunity for the UK Government to introduce direct incentives to stimulate growth in the life sciences sector. The report explores how these incentives, combined with other initiatives, can drive job creation and economic growth across R&D and manufacturing. By fostering a supportive environment for innovation, the UK can strengthen its position as a global leader in life sciences.
Investment in life sciences is not just about financial input; it also encompasses creating an ecosystem that nurtures innovation. This includes providing support for startups and small to medium-sized enterprises (SMEs) that are often at the forefront of pioneering research. By offering tax incentives, grants, and other financial support, the Government can encourage these companies to invest in new technologies and expand their operations.
Additionally, investment in infrastructure is crucial. Modern research facilities, advanced manufacturing plants, and state-of-the-art laboratories are essential for conducting high-quality research and development. The Government can play a pivotal role in developing such infrastructure, ensuring that the UK has the physical capacity to support cutting-edge research and large-scale production of new medical technologies.
Job creation is another significant aspect of this strategy. By fostering growth in the life sciences sector, the UK can create high-skilled jobs that contribute to the economy. These jobs span various fields, including research, engineering, manufacturing, and regulatory affairs. A thriving life sciences sector not only provides employment opportunities but also attracts talent from around the world, further enhancing the UK’s position as a global leader in this field.
Case Study
2. IQVIA: PATHFINDER: Accelerating the Lung Cancer Patient
IQVIA’s PATHFINDER initiative aimed to improve lung cancer survival rates in the UK by ensuring timely diagnosis and treatment access. Collaboration between the NHS, AstraZeneca, and IQVIA focused on identifying and addressing inefficiencies in patient pathways. Key interventions included data analysis, deep-dive assessments, and implementing recommendations to streamline care. Results showed significant improvements: patient review times reduced from five days to under 24 hours, PET-CT scan wait times cut from five-seven days to two, and 80% of samples reached labs on the same day. PATHFINDER’s success illustrates the potential of digital health technologies in enhancing NHS patient care pathways.
How to Get Involved
The Curia report, developed in partnership with the LSE, and sponsors IQVIA and Genomics PLC offers a comprehensive blueprint for revitalising the UK’s life sciences sector. By focusing on clinically engaged approaches, investment and growth, regulatory frameworks, clinical uptake, and robust governance, the report provides a clear path forward for leveraging the UK’s strengths. For those in the public sector and Curia subscribers, the reader will see recommendations that aim to ensure that the UK remains at the forefront of life sciences innovation, delivering tangible benefits for patients and the economy alike.
Following the outcome of the general election, the new Government must take decisive action to harness the UK’s world-leading scientific expertise, advanced healthcare infrastructure, and pioneering AI capabilities. With the right strategic priorities and public policy measures in place, the UK can reclaim its position as a global leader in life sciences and secure a sustainable future for its healthcare system.
Implementing these recommendations will require commitment and collaboration from all stakeholders involved. That means we need your help. Over the coming months, Curia will work with the new Government to help them implement the recommendations in this report, supporting with views about best ways to operationalise their manifesto commitments. To do this we require the help of the NHS to feed in their thoughts and for the life sciences sector to highlight examples of best practice that will highlight new ways of working.
For those who will be able to read the evidence contained in the report, the case studies and the recommendations, your feedback will be incredibly helpful – not just for the Health, Care, and Life Sciences Advisory Board, but also for new Ministers as they navigate their implementation plans.
The challenges are significant, but so are the opportunities. By working together, the UK can create a vibrant and dynamic life sciences sector that drives innovation, improves patient outcomes, and contributes to economic growth.
This is just one of the articles that features in the Health, Care and Life Sciences section of Chamber UK’s pre-election journal. To gain full access, please subscribe here.
